CAS 63177-57-1: Methyl 2,5-dihydroxycinnamate
Formula:C10H10O4
InChI:InChI=1/C10H10O4/c1-14-10(13)5-2-7-6-8(11)3-4-9(7)12/h2-6,11-12H,1H3/b5-2+
- Synonyms:
- 2,4-Dihydroxymethylcinnamate
- 2,5-Dihydroxycinnamic acid methyl ester
- Methyl 3-(2,5-dihydroxyphenyl)-2-propenoate
- 2-Propenoic acid, 3-(2,5-dihydroxyphenyl)-, methyl ester
- methyl (2E)-3-(2,5-dihydroxyphenyl)prop-2-enoate

Methyl 2,5-Dihydroxycinnamate
CAS:63177-57-1
Formula:
C10H10O4
Purity:
>96.0%(HPLC)
Color and Shape:
White to Yellow powder to crystal
Molecular weight:
194.19
Ref: 3B-M2520
10mg | 64.00 € | ||
100mg | 365.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025

METHYL 2,5-DIHYDROXYCINNAMATE
CAS:63177-57-1
Formula:
C10H10O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
194.184
Ref: IN-DA00E8PA
5mg | 97.00 € | ||
10mg | 121.00 € | ||
25mg | 153.00 € | ||
100mg | 181.00 € | ||
250mg | 207.00 € |
Estimated delivery in United States, on Tuesday 25 Mar 2025

Methyl 2,5-dihydroxycinnamate
CAS:63177-57-1
Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
Formula:
C10H10O4
Purity:
98.98%
Color and Shape:
Crystalline
Molecular weight:
194.18
Ref: TM-T22974
5mg | 60.00 € | ||
10mg | 96.00 € | ||
25mg | 187.00 € | ||
50mg | 354.00 € | ||
100mg | 528.00 € | ||
1mL*10mM (DMSO) | 60.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025

Ref: 10-F601081
5mg | 94.00 € | ||
10mg | 150.00 € | ||
25mg | 184.00 € | ||
50mg | 566.00 € | ||
100mg | 199.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 2 Apr 2025

Methyl 2,5-dihydroxycinnamate
CAS:63177-57-1
Methyl 2,5-dihydroxycinnamate is a tyrosine kinase inhibitor that is used in the treatment of squamous …
Formula:
C10H10O4
Purity:
Min. 95%
Molecular weight:
194.18 g/mol
Ref: 3D-FM25380
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |